DE69415320T2 - Verfahren und vorrichtung zur herstellung von partikeln unter verwendung eines superkritischen mediums - Google Patents

Verfahren und vorrichtung zur herstellung von partikeln unter verwendung eines superkritischen mediums

Info

Publication number
DE69415320T2
DE69415320T2 DE69415320T DE69415320T DE69415320T2 DE 69415320 T2 DE69415320 T2 DE 69415320T2 DE 69415320 T DE69415320 T DE 69415320T DE 69415320 T DE69415320 T DE 69415320T DE 69415320 T2 DE69415320 T2 DE 69415320T2
Authority
DE
Germany
Prior art keywords
pct
screens
date jan
sec
run
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69415320T
Other languages
English (en)
Other versions
DE69415320D1 (de
Inventor
Mazen Hanna
Peter York
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nektar Therapeutics
Original Assignee
Bradford Particle Design Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10738144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69415320(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bradford Particle Design Ltd filed Critical Bradford Particle Design Ltd
Application granted granted Critical
Publication of DE69415320D1 publication Critical patent/DE69415320D1/de
Publication of DE69415320T2 publication Critical patent/DE69415320T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B01F25/42—Static mixers in which the mixing is affected by moving the components jointly in changing directions, e.g. in tubes provided with baffles or obstructions
    • B01F25/43—Mixing tubes, e.g. wherein the material is moved in a radial or partly reversed direction
    • B01F25/435—Mixing tubes composed of concentric tubular members
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
    • B05B7/02—Spray pistols; Apparatus for discharge
    • B05B7/06—Spray pistols; Apparatus for discharge with at least one outlet orifice surrounding another approximately in the same plane
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2401/00—Form of the coating product, e.g. solution, water dispersion, powders or the like
    • B05D2401/90—Form of the coating product, e.g. solution, water dispersion, powders or the like at least one component of the composition being in supercritical state or close to supercritical state

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Paper (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Glanulating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69415320T 1993-07-01 1994-06-30 Verfahren und vorrichtung zur herstellung von partikeln unter verwendung eines superkritischen mediums Expired - Lifetime DE69415320T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313642A GB9313642D0 (en) 1993-07-01 1993-07-01 Method and apparatus for the formation of particles
PCT/GB1994/001426 WO1995001221A1 (en) 1993-07-01 1994-06-30 Method and apparatus for the formation of particles

Publications (2)

Publication Number Publication Date
DE69415320D1 DE69415320D1 (de) 1999-01-28
DE69415320T2 true DE69415320T2 (de) 1999-06-24

Family

ID=10738144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69415320T Expired - Lifetime DE69415320T2 (de) 1993-07-01 1994-06-30 Verfahren und vorrichtung zur herstellung von partikeln unter verwendung eines superkritischen mediums

Country Status (15)

Country Link
US (1) US5851453A (de)
EP (1) EP0706421B1 (de)
JP (3) JPH08511987A (de)
AT (1) ATE174530T1 (de)
AU (1) AU677345B2 (de)
CA (1) CA2166301C (de)
DE (1) DE69415320T2 (de)
DK (1) DK0706421T3 (de)
ES (1) ES2128564T3 (de)
GB (1) GB9313642D0 (de)
GR (1) GR3029612T3 (de)
IN (1) IN179851B (de)
NZ (1) NZ267697A (de)
SG (1) SG47392A1 (de)
WO (1) WO1995001221A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19640027B4 (de) * 1995-09-29 2008-04-30 Karasawa, Yukihiko, Ohmiya Verfahren und Vorrichtung zum Pulverisieren fester Teilchen

Families Citing this family (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063910A (en) * 1991-11-14 2000-05-16 The Trustees Of Princeton University Preparation of protein microparticles by supercritical fluid precipitation
DE69415998T2 (de) 1993-11-08 1999-08-12 Gillette Co Verfahren zur formung von partikeln unter verwendung einer überkritischen flüssigkeit so hergestellte aerogelpartikel und aerogelpartikel enthaltenden antiperspirantien
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US5874029A (en) * 1996-10-09 1999-02-23 The University Of Kansas Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
US5833891A (en) * 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
FR2753639B1 (fr) † 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
GB9703673D0 (en) 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
SE9701956D0 (sv) * 1997-05-23 1997-05-23 Astra Ab New composition of matter
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
DE19748069A1 (de) * 1997-10-31 1999-05-06 Messer Griesheim Gmbh Verfahren und Vorrichtung zum Abkühlen und Zerstäuben von flüssigen oder pastösen Stoffen
GB9804379D0 (en) * 1998-03-02 1998-04-22 Bradford Particle Design Ltd Method of particle formation
GB9810559D0 (en) * 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
US6048369A (en) * 1998-06-03 2000-04-11 North Carolina State University Method of dyeing hydrophobic textile fibers with colorant materials in supercritical fluid carbon dioxide
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
US6113795A (en) * 1998-11-17 2000-09-05 The University Of Kansas Process and apparatus for size selective separation of micro- and nano-particles
SE9804000D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New composition of matter
SE9804001D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New process
GB9828204D0 (en) * 1998-12-21 1999-02-17 Smithkline Beecham Plc Process
US6630121B1 (en) 1999-06-09 2003-10-07 The Regents Of The University Of Colorado Supercritical fluid-assisted nebulization and bubble drying
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
GB9915975D0 (en) * 1999-07-07 1999-09-08 Bradford Particle Design Ltd Method for the formation of particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
EP1090894A1 (de) * 1999-10-06 2001-04-11 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung feinpartikulärer Explosivstoffe
GB9927011D0 (en) 1999-11-16 2000-01-12 Advanced Phytonics Ltd Method for the production of particles
FR2802445B1 (fr) * 1999-12-15 2002-02-15 Separex Sa Procede et dispositif de captage de fines particules par piegeage au sein d'un melange solide de type neige carbonique
FR2803538B1 (fr) * 1999-12-15 2002-06-07 Separex Sa Procede et dispositif de captage de fines particules par percolation dans un lit de granules
US6761909B1 (en) 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
AU2729101A (en) * 1999-12-21 2001-07-03 Rxkinetix, Inc. Particulate drug-containing products and method of manufacture
US6261326B1 (en) 2000-01-13 2001-07-17 North Carolina State University Method for introducing dyes and other chemicals into a textile treatment system
US7029700B2 (en) * 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
JP2003525731A (ja) 2000-03-03 2003-09-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 溶剤膨張−収縮の繰り返しによる物質処理方法
CH694686A5 (it) 2000-03-04 2005-06-15 Eco2 Sa Prodotto di micronizzazione di sostanze farmaceutiche.
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US6620351B2 (en) 2000-05-24 2003-09-16 Auburn University Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
TWI236930B (en) 2000-05-26 2005-08-01 Pfizer Prod Inc Reactive crystallization method to improve particle size
GB0016002D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
WO2002020538A2 (en) * 2000-09-06 2002-03-14 Bristol-Myers Squibb Company Stavudine polymorphic form 1 process
US6521258B1 (en) * 2000-09-08 2003-02-18 Ferro Corporation Polymer matrices prepared by supercritical fluid processing techniques
US6676710B2 (en) 2000-10-18 2004-01-13 North Carolina State University Process for treating textile substrates
FR2815540B1 (fr) † 2000-10-19 2005-06-10 Separex Sa Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote
US8551526B2 (en) * 2000-11-03 2013-10-08 Board Of Regents, The University Of Texas System Preparation of drug particles using evaporation precipitation into aqueous solutions
US6756062B2 (en) 2000-11-03 2004-06-29 Board Of Regents University Of Texas System Preparation of drug particles using evaporation precipitation into aqueous solutions
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AU2002221320B2 (en) * 2000-12-08 2006-06-15 The University Of Sydney Synthesis of small particles
AUPR197000A0 (en) 2000-12-08 2001-01-11 Unisearch Limited Synthesis of small particles
JP2005504715A (ja) 2000-12-29 2005-02-17 アドバンスト インハレーション リサーチ，インコーポレイテッド 持続放出特性を有する吸入用粒子
US20110301569A1 (en) 2001-01-20 2011-12-08 Gordon Wayne Dyer Methods and apparatus for the CVCS
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
CA2438275C (en) * 2001-02-26 2010-05-25 Dompe S.P.A. Apparatus and method for micron and submicron particle formation
WO2002089851A1 (fr) * 2001-03-06 2002-11-14 Separex (Societe Anonyme) Procede de fabrication de complexes hote-client
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
WO2003004142A1 (en) * 2001-07-02 2003-01-16 Micro & Nano Materials Sagl Process for the production of micro and/or nano particles
WO2003006223A1 (en) * 2001-07-10 2003-01-23 University Technology Corporation Devices and methods for the production of particles
TW586963B (en) * 2001-07-20 2004-05-11 Nektar Therapeutics Uk Ltd Method and apparatus for preparing target substance in particulate form and fluid inlet assembly for said apparatus
GB0208742D0 (en) * 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0117696D0 (en) 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
EA006064B1 (ru) 2001-10-10 2005-08-25 Бёрингер Ингельхайм Фармасьютиклз, Инк. Способ обработки порошков сжиженными газами
FR2830760B1 (fr) 2001-10-12 2004-06-04 Pf Medicament Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique
PT1440082E (pt) 2001-10-22 2011-12-07 Dompe Spa Processamento de fluidos supercríticos: preparação de micropartículas de proteína e sua estabilização
ES2415654T3 (es) 2001-11-20 2013-07-26 Civitas Therapeutics, Inc. Composiciones particuladas mejoradas para suministro pulmonar
US7641823B2 (en) 2001-12-07 2010-01-05 Map Pharmaceuticals, Inc. Synthesis of small particles
EP1458360B1 (de) 2001-12-19 2011-05-11 Novartis AG Pulmonale verabreichung von aminoglykosiden
EP1463574A1 (de) * 2002-01-08 2004-10-06 Extractis International Ltd Ölextraktionsverfahren und vorrichtung dafür
DE10203629A1 (de) * 2002-01-30 2003-07-31 Ulrich Zimmermann Vorrichtung und Verfahren zur Herstellung von Mikrokapseln sowie verbesserte Mikrokapsel
CA2478327A1 (en) * 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Hgh (human growth hormone) formulations for pulmonary administration
US7008644B2 (en) * 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
US20050163725A1 (en) * 2002-03-20 2005-07-28 Blizzard Charles D. Method for administration of growth hormone via pulmonary delivery
GB2405334B (en) * 2002-04-17 2006-02-15 Nektar Therapeutics Uk Ltd Particulate materials
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
WO2003090715A2 (en) * 2002-04-25 2003-11-06 Nektar Therapeutics Uk Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
AU2003297391B2 (en) * 2002-12-19 2010-02-25 Baxter International, Inc. Process for preparing combination pharmaceutical formulations using supercritical fluids
CA2508870C (en) 2002-12-30 2012-10-16 Nektar Therapeutics Prefilming atomizer
JP2004264346A (ja) * 2003-02-05 2004-09-24 Sharp Corp 現像剤及びその製造方法
WO2004071645A2 (en) * 2003-02-07 2004-08-26 Ferro Corporation Method and apparatus for supercritical fluid assisted particle production
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
FR2854079B1 (fr) 2003-04-25 2007-11-30 Pf Medicament Procede de preparation de complexes moleculaires
MY147403A (en) * 2003-04-29 2012-11-30 Kowa Co Composition containing medicine extremely slightly solube in water and method for preparation thereof
US20060008531A1 (en) 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
JP2006525303A (ja) * 2003-05-08 2006-11-09 ネクター セラピューティクス ユーケー リミティド 微粒子物質
US7767118B2 (en) 2003-06-03 2010-08-03 Ferro Corporation Nanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants
JP3663408B2 (ja) * 2003-06-30 2005-06-22 株式会社アイテック 高温高圧水を用いる微粒子製造方法および微粒子製造装置
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
AU2004277419B2 (en) * 2003-09-30 2007-10-11 Brown University Research Foundation Nanoparticulate therapeutic biologically active agents
WO2005042219A1 (en) * 2003-10-24 2005-05-12 Ferro Corporation Method of forming particles
SE0303476D0 (sv) 2003-12-22 2003-12-22 Censdelivery Ab Device, method and use for the formation of small particles
EP1729729B1 (de) * 2004-03-23 2014-04-23 Novartis AG Pharmazeutische zusammensetzungen
US7220456B2 (en) 2004-03-31 2007-05-22 Eastman Kodak Company Process for the selective deposition of particulate material
US7223445B2 (en) * 2004-03-31 2007-05-29 Eastman Kodak Company Process for the deposition of uniform layer of particulate material
KR101054129B1 (ko) * 2004-03-31 2011-08-03 이스트맨 코닥 캄파니 균일한 미립자 물질층의 침착
US20050218076A1 (en) * 2004-03-31 2005-10-06 Eastman Kodak Company Process for the formation of particulate material
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
US8513204B2 (en) 2004-06-21 2013-08-20 Novartis Ag Compositions comprising amphotericin B, mehods and systems
MXPA06015220A (es) 2004-06-21 2007-12-13 Nektar Therapeutics Composiciones comprendiendo anfotericina b, metodos y sistemas.
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan
WO2006063025A1 (en) * 2004-12-07 2006-06-15 Nektar Therapeutics Stable non-crystalline formulation comprising donepezil
JP5016785B2 (ja) * 2004-12-28 2012-09-05 株式会社奈良機械製作所 微細粒子の生成装置
JP4635154B2 (ja) * 2005-02-22 2011-02-16 日本工機株式会社 微粒子化合火薬類の微粒子生成装置、微粒子化合火薬類の製造装置および微粒子化合火薬類の製造方法
US8079838B2 (en) * 2005-03-16 2011-12-20 Horiba, Ltd. Pure particle generator
WO2006132242A1 (ja) * 2005-06-09 2006-12-14 Toss Ltd. 超微小粒子の製造方法
CA2615378C (en) * 2005-07-15 2015-02-17 Map Pharmaceuticals, Inc. Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
US8475845B2 (en) * 2005-07-15 2013-07-02 Map Pharmaceuticals, Inc. Method of particle formation
EP1782839A1 (de) 2005-11-03 2007-05-09 Genetic S.p.A. Verfahren zur Sterilisation von Glucocorticosteroiden mit überkritischem CO2
FR2898516B1 (fr) * 2006-03-17 2008-05-30 Innov Ia Sa Procede de preparation d'une composition pulverulente et produit tel qu'obtenu
JP2010505605A (ja) * 2006-10-06 2010-02-25 ニューサウス イノベーションズ ピーティーワイ リミテッド 粒子の形成
EP2476412B1 (de) * 2006-10-11 2014-03-19 Crititech, Inc. Apparat zur Abscheidung kleiner Medikamententeilchen in einen Behälter
KR20090089838A (ko) * 2006-12-01 2009-08-24 데이진 화이바 가부시키가이샤 고분자 성형물에 대한 기능 부여 방법 및 그 장치
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
GB0702402D0 (en) 2007-02-08 2007-03-21 Thar Pharmaceuticals Inc Method of creating crystalline substances
EP2425820B1 (de) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Verfahren zur therapeutischen Verabreichung von DHE zur schnellen Linderung von Migräne bei gleichzeitiger Minimierung von Nebenwirkungsprofilen
FR2915405B1 (fr) * 2007-04-30 2011-09-09 Areva Np Preparation de particules minerales en milieu co2 supercritique
WO2009047935A1 (ja) * 2007-10-12 2009-04-16 Ono Pharmaceutical Co., Ltd. 微粒子
PL2229233T3 (pl) 2007-12-07 2020-03-31 Xspray Pharma Ab (Publ) Sposób wytwarzania cząstek
EP2258748B1 (de) 2008-03-24 2019-05-08 Sanyo Chemical Industries, Ltd. Kunstharzpartikel und verfahren zu ihrer herstellung
CA2725578A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
WO2009140587A1 (en) 2008-05-15 2009-11-19 Novartis Ag Pulmonary delivery of a fluoroquinolone
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
EP2191821A1 (de) 2008-11-26 2010-06-02 CHIESI FARMACEUTICI S.p.A. Mikropartikel enthaltend ein Salz von 8-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone mit verbesserten Adhesionseigenschaften zur Trockenpulver-Inhalation
FR2945110B1 (fr) * 2009-04-30 2012-09-21 Air Liquide Procede et installation de melange et de refroidissement d'un produit
US20100291221A1 (en) * 2009-05-15 2010-11-18 Robert Owen Cook Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
US20100298602A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Systems and methods for microfluidic crystallization
US20100294986A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Supercritical fluid facilitated particle formation in microfluidic systems
DK2435024T3 (en) 2009-05-29 2016-10-24 Pearl Therapeutics Inc Compositions for the respiratory delivery of active agents and related methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR100924236B1 (ko) * 2009-06-23 2009-10-29 충남대학교산학협력단 균일한 입도분포를 가지는 초미세입자의 신규한 제조방법 및 장치
ES2623328T3 (es) * 2009-09-18 2017-07-11 Sitec Pharmabio Sl Procedimiento para la deshidratación de productos en polvo
WO2011116763A1 (de) * 2010-03-22 2011-09-29 Mjr Pharmjet Gmbh Verfahren und vorrichtung zur herstellung von mikro- oder nanopartikeln
HUE037788T2 (hu) 2010-04-01 2018-09-28 Univ Alberta Nagy molekulatömegû biopolimerek kezelése szuperkritikus folyadékkal
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
JP5933234B2 (ja) * 2011-11-24 2016-06-08 国立大学法人東北大学 微粒子作製装置
US8778181B1 (en) * 2013-03-14 2014-07-15 Crititech, Inc. Equipment assembly for and method of processing particles
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
US20170050337A1 (en) * 2013-05-02 2017-02-23 Melior Innovations, Inc. Formation apparatus, systems and methods for manufacturing polymer derived ceramic structures
RU2015154720A (ru) 2013-05-22 2017-06-27 Перл Терапьютикс, Инк. Композиции, способы и системы для респираторной доставки трех или более активных средств
EP3054921A4 (de) * 2013-10-10 2017-03-15 New York University Effiziente erfassung von nanopartikeln
GB201402556D0 (en) 2014-02-13 2014-04-02 Crystec Ltd Improvements relating to inhalable particles
JP6921759B2 (ja) 2015-06-04 2021-08-18 クリティテック・インコーポレイテッド 捕集装置および使用法
DE102015007604A1 (de) * 2015-06-12 2016-12-29 Messer France S.A.S Vorrichtung und Verfahren zum Kühlen und Zerstäuben flüssiger oder pastöser Stoffe
CN108026059A (zh) 2015-07-22 2018-05-11 阿纳韦克斯生命科学公司 四氢-n，n-二甲基-2，2-二苯基-3-呋喃甲胺盐酸盐的晶型，制备这样晶型的方法，及其药物组合物
PL3353232T3 (pl) * 2015-09-25 2021-05-04 Sappi Netherlands Services B.V. Suszenie rozpyłowe celulozy nadkrytycznym CO2
TW202317080A (zh) 2021-07-09 2023-05-01 美商阿斯特捷利康有限責任公司 用於氣溶膠遞送之組合物、方法及系統
EP4190437A1 (de) 2021-12-03 2023-06-07 SiTec PharmaBio SL Verfahren und vorrichtung zur herstellung von festen mikropartikeln
WO2023119093A1 (en) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, methods and systems for aerosol drug delivery
WO2023212191A1 (en) 2022-04-28 2023-11-02 Astrazeneca Ab Combination of albuterol and budesonide for the treatment of asthma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1078283B (de) * 1958-06-12 1960-03-24 Bayer Ag Verfahren zur Umhuellung oder Einbettung von pharmazeutischen Wirkstoffen
BE795724A (fr) * 1972-02-25 1973-08-21 Basf Ag Procede et dispositif de fabrication de fibres courtes en matieres synthetiques thermoplastiques
US4422985A (en) * 1982-09-24 1983-12-27 Morishita Jintan Co., Ltd. Method and apparatus for encapsulation of a liquid or meltable solid material
US4734227A (en) * 1983-09-01 1988-03-29 Battelle Memorial Institute Method of making supercritical fluid molecular spray films, powder and fibers
DE3744329A1 (de) * 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
FR2663223B1 (fr) * 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
DE4319990A1 (de) * 1993-06-17 1994-12-22 Messer Griesheim Gmbh Verfahren zum Herstellen von Teilchen aus Kunststoffen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19640027B4 (de) * 1995-09-29 2008-04-30 Karasawa, Yukihiko, Ohmiya Verfahren und Vorrichtung zum Pulverisieren fester Teilchen

Also Published As

Publication number Publication date
AU7007194A (en) 1995-01-24
JP2006239686A (ja) 2006-09-14
ES2128564T3 (es) 1999-05-16
JP2004105953A (ja) 2004-04-08
DE69415320D1 (de) 1999-01-28
ATE174530T1 (de) 1999-01-15
SG47392A1 (en) 1998-04-17
GB9313642D0 (en) 1993-08-18
WO1995001221A1 (en) 1995-01-12
CA2166301C (en) 2003-01-14
US5851453A (en) 1998-12-22
IN179851B (de) 1997-12-27
JPH08511987A (ja) 1996-12-17
EP0706421B1 (de) 1998-12-16
AU677345B2 (en) 1997-04-17
EP0706421A1 (de) 1996-04-17
CA2166301A1 (en) 1995-01-12
GR3029612T3 (en) 1999-06-30
JP3806107B2 (ja) 2006-08-09
NZ267697A (en) 1997-05-26
DK0706421T3 (da) 1999-08-23

Similar Documents

Publication Publication Date Title
DE69415320T2 (de) Verfahren und vorrichtung zur herstellung von partikeln unter verwendung eines superkritischen mediums
BR9407611A (pt) Processo de produção de papel papel documento de segurança e aparelho para a produção de papel
ATE170578T1 (de) Mahlgarnitur
ATE203389T1 (de) Verfahren und vorrichtung zur herstellung einer aus cellulose-fasern bestehenden faserstoffbahn für die verwendung in hygieneartikeln
HUT71186A (en) A method of producing visible, continous streaks and/or delimited fields in paper
ATE40431T1 (de) Verfahren und vorrichtung zum praegen eines trockengefertigten faserbandes, zum beispiel einer kuechenpapierrolle.
GB2300429B (en) Non-woven fabric manufacture
DE69530679D1 (de) Vorrichtung zur durchbiegungssteuerung der walzen in einer maschine zum krumpfen von warenbahnen
ATE209600T1 (de) Verfahren und wickelmaschine zum aufwickeln von papier- oder kartonbahnen
ATE157411T1 (de) Vorrichtung und verfahren zum behandeln eines abfallpapierstoffbreis
DE69715984T2 (de) Apparat zur Herstellung eines Filtermediums in Blattform
DE69220160D1 (de) Verfahren und vorrichtung zur verbesserten doppelsiebformation
FR2171033A2 (en) Fibrous non-woven web - formed by filtering fibrous suspension on inclined screen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BRADFORD PARTICLE DESIGN LTD., BRADFORD, GB

8363 Opposition against the patent
R082 Change of representative

Ref document number: 706421

Country of ref document: EP

Representative=s name: LEINWEBER & ZIMMERMANN, DE

R081 Change of applicant/patentee

Ref document number: 706421

Country of ref document: EP

Owner name: NEKTAR THERAPEUTICS, US

Free format text: FORMER OWNER: BRADFORD PARTICLE DESIGN LTD., BRADFORD, GB

Effective date: 20121113

R082 Change of representative

Ref document number: 706421

Country of ref document: EP

Representative=s name: LEINWEBER & ZIMMERMANN, DE

Effective date: 20121113